Related references
Note: Only part of the references are listed.Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
Delilah Hendriks et al.
NATURE BIOTECHNOLOGY (2023)
A framework for fibrolamellar carcinoma research and clinical trials
Timothy A. Dinh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Human liver organoids for disease modeling of fibrolamellar carcinoma
Nicole J. C. Narayan et al.
STEM CELL REPORTS (2022)
DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
Nevi Lorenzo et al.
HEPATOLOGY (2021)
Deregulation of ribosomal proteins in human cancers
Wendy El Khoury et al.
BIOSCIENCE REPORTS (2021)
Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver
Delilah Hendriks et al.
NATURE PROTOCOLS (2021)
Fibrolamellar carcinoma: An entity all its own
Allison F. O'Neill et al.
CURRENT PROBLEMS IN CANCER (2021)
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar et al.
CANCER DISCOVERY (2021)
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
Leonardo Baiocchi et al.
CELLS (2021)
Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer
Martha D. Gay et al.
CANCER PREVENTION RESEARCH (2021)
Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma
Kenta Kawasaki et al.
GASTROENTEROLOGY (2020)
Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma
Mark L. Jewell et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing
Benedetta Artegiani et al.
NATURE CELL BIOLOGY (2020)
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Panagiota S. Filippou et al.
ONCOGENE (2020)
Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities
Timothy A. Dinh et al.
CELL REPORTS (2020)
Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver
Imane El Dika et al.
CANCER (2020)
BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice
Stephanie Perkail et al.
NATURE COMMUNICATIONS (2020)
Complex roles of cAMP-PKA-CREB signaling in cancer
Hongying Zhang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Delilah Hendriks et al.
CELL STEM CELL (2020)
Kruppel-like Factor Regulates Sternness, Lineage Specification, and Regneration of Intestinal Epithelial Stern Cells
Chang-Kyung Kim et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis
Aldona Kasprzak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids
Benedetta Artegiani et al.
CELL STEM CELL (2019)
An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
Rigney E. Turnham et al.
ELIFE (2019)
A human liver cell atlas reveals heterogeneity and epithelial progenitors
Nadim Aizarani et al.
NATURE (2019)
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
Théo Z. Hirsch et al.
JOURNAL OF HEPATOLOGY (2019)
Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1
Meng He et al.
SCIENCE (2019)
Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma
Margaret A. Hill et al.
CANCER RESEARCH (2018)
Role of cAMP and phosphodiesterase signaling in liver health and disease
Banrida Wahlang et al.
CELLULAR SIGNALLING (2018)
Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion
Rondell P. Graham et al.
HEPATOLOGY (2018)
Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms
Gadi Lalazar et al.
SEMINARS IN LIVER DISEASE (2018)
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang et al.
NATURE CELL BIOLOGY (2018)
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
Huili Hu et al.
CELL (2018)
Management of fibrolamellar hepatocellular carcinoma
Vikram A. Chaudhari et al.
CHINESE CLINICAL ONCOLOGY (2018)
CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma
Lars H. Engelholm et al.
GASTROENTEROLOGY (2017)
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
Angela Bononi et al.
NATURE (2017)
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation
Eric C. Sorenson et al.
PLOS ONE (2017)
DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma
Edward R. Kastenhuber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
Timothy A. Dinh et al.
SCIENTIFIC REPORTS (2017)
A genomic case study of mixed fibrolamellar hepatocellular carcinoma
O. L. Griffith et al.
ANNALS OF ONCOLOGY (2016)
Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation
Laura Broutier et al.
NATURE PROTOCOLS (2016)
Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma
Kevin M. Riggle et al.
PEDIATRIC RESEARCH (2016)
Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma
Guang-Yao Li et al.
ONCOTARGETS AND THERAPY (2016)
Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
Qing Li et al.
ONCOTARGET (2016)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts
Alexis Poncy et al.
DEVELOPMENTAL BIOLOGY (2015)
Carney complex: an update
Ricardo Correa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
Helena Cornella et al.
GASTROENTEROLOGY (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
Transcriptomic characterization of fibrolamellar hepatocellular carcinoma
Elana P. Simon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Structural insights into mis-regulation of protein kinase A in human tumors
Jonah Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
Tsunekazu Oikawa et al.
NATURE COMMUNICATIONS (2015)
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients
David G. Darcy et al.
ONCOTARGET (2015)
FUCCI sensors: powerful new tools for analysis of cell proliferation
N. Zielke et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Genomic analysis of fibrolamellar hepatocellular carcinoma
Lei Xu et al.
HUMAN MOLECULAR GENETICS (2015)
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
Olivier Govaere et al.
GUT (2014)
Transcriptional Profiling of Pure Fibrolamellar Hepatocellular Carcinoma Reveals an Endocrine Signature
Gabriel G. Malouf et al.
HEPATOLOGY (2014)
The Biliary Epithelium Gives Rise to Liver Progenitor Cells
Daniel Rodrigo-Torres et al.
HEPATOLOGY (2014)
Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
Helen Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Dclk1 distinguishes between tumor and normal stem cells in the intestine
Yuki Nakanishi et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Cholangiocarcinomas can originate from hepatocytes in mice
Biao Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Cyclic AMP Pathway
Paolo Sassone-Corsi
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Fibrolamellar Hepatocellular Carcinoma: An Immunohistochemical Comparison With Conventional Hepatocellular Carcinoma
Hala M. Abdul-Al et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2010)
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation
Stephen C. Ward et al.
MODERN PATHOLOGY (2010)
Unique Phenotype of Hepatocellular Cancers with Exon-3 Mutations in Beta-Catenin Gene
Benjamin Cieply et al.
HEPATOLOGY (2009)
Foxl1 Is a Marker of Bipotential Hepatic Progenitor Cells in Mice
Sara D. Sackett et al.
HEPATOLOGY (2009)
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization
Karen H. Ventii et al.
CANCER RESEARCH (2008)
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway
H Francis et al.
JOURNAL OF HEPATOLOGY (2004)
Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma
SK Lau et al.
HUMAN PATHOLOGY (2002)
Share Paper
